Apply an appropriate amount of M605110 once a day.

2 trials

Sponsors

Tomoyuki Nishiura

Conditions

Acne vulgaris

Phase 3

A phase III study to evaluate the efficacy and safety of M605110 in patients with acne vulgaris

Active, not recruitingJPRN-jRCT2031220334

Tomoyuki NishiuraAcne vulgaris

Start: 2022-10-04Target: 40Updated: 2026-06-29

A phase III study to evaluate the efficacy and safety of M605110 in patients with acne vulgaris

Active, not recruitingJPRN-jRCT2031220333

Tomoyuki NishiuraAcne vulgaris

Start: 2022-09-30Target: 240Updated: 2026-06-29